Search the Newsreel

Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13

Capricor Therapeutics announced it will release its second quarter 2026 financial results after market close on Thursday, August 13, 2026. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results and provide a …

Capricor Therapeutics (NASDAQ:CAPR) Securities Class Action Notice: Investors who Lost Money when Stock Plummeted 64% are Notified to Contact BFA Law by September 28

Capral (ASX:CAA) Builds Shareholder Value Through Cash Generation and Aluminium Strategy

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain of its officers, alleging violations of federal securities laws. The lawsuit seeks to recover damages for investors who purchased Capricor securities …

Capri Holdings Limited (CPRI) stock price, news, quote and history

This article provides a detailed financial overview of Capri Holdings Limited (CPRI), including its current stock price, historical data, key statistics, and analyst insights. It covers the company's business segments (Michael Kors and Jimmy Choo), financial performance, and comparisons with other luxury goods companies. …

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made undisclosed changes to its statistical analysis …

Capri Holdings Limited (CPRI) latest stock news and headlines

This article provides a compilation of recent news and headlines concerning Capri Holdings Limited (CPRI), a luxury fashion company. It includes updates on earnings performance, analyst ratings, stock valuation, and investor relations announcements. The news covers insights from various financial sources like Zacks, Simply …

Capri Holdings (CPRI) Could Be 39% Undervalued As Fresh Guidance Resets The Debate

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Capri Holdings (CPRI) has just updated investors with fresh guidance for the second quarter and full fiscal 2027. The company also released first …

Capri Holdings (CPRI) Reports Higher EPS, Is The Stock Still Cheap?

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

ClaimsFiler is alerting investors of Capricor Therapeutics (CAPR) who suffered losses exceeding $100,000 about an upcoming lead plaintiff deadline in a class action lawsuit. The lawsuit alleges that Capricor and its executives failed to disclose material information regarding changes to the statistical analysis plan …

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Kahn Swick & Foti, LLC (KSF) has announced a class action securities lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) for investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor and its executives failed to disclose material …

Tangible book value per share of Capricor Therapeutics, Inc. – HAM:4LN2

This article provides the tangible book value per share for Capricor Therapeutics, Inc. (HAM:4LN2). It notes that the market for this stock on the Hamburg Stock Exchange is currently closed with no trades. The information is presented within the context of TradingView's financial data …

FMR LLC (CPRI) discloses 2.15M Capri Holdings shares in Schedule 13G/A

FMR LLC has filed an amended Schedule 13G/A, disclosing beneficial ownership of 2,151,978.73 shares of Capri Holdings Ltd (CPRI), which represents 1.9% of the company's common stock as of July 31, 2026. The filing indicates FMR LLC has sole dispositive power over all these …

State Street Corporation (NASDAQ: CAPR custodian) holds 5.9% of Capricor Therapeutics

State Street Corporation has filed a Schedule 13G, disclosing a beneficial ownership of 5.9% of Capricor Therapeutics Inc. common stock, totaling 3,397,241 shares. The filing indicates that State Street holds 3,285,634 shares with shared voting power and 3,397,241 shares with shared dispositive power, primarily …

Capri Holdings (NYSE: CPRI) sees FMR LLC report 7% ownership stake

FMR LLC and Abigail P. Johnson have reported a 7.0% passive ownership stake in Capri Holdings Ltd (NYSE: CPRI) through an amended Schedule 13G/A filing. FMR LLC beneficially owns 8,029,528.97 shares, with sole voting power over 6,874,881.48 shares and sole dispositive power over all …

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (CAPR) Who Suffered Losses to Contact the Firm Before September 28, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor's stock price fell significantly after the FDA released …

CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit

Hagens Berman has filed a securities fraud class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) following allegations that the company made misleading statements about its Deramiocel clinical trial data and regulatory pathway. Investors who suffered substantial losses between December 17, 2025, and July …

Capri Global Capital files Aug 2026 presentation with Q1FY27 results

Capricorn Metals (ASX:CMM) Could Be 73% Undervalued Following Its Growth Update

Capri Holdings stock hits 52-week low at 15.19 USD

Capri Holdings (CPRI) stock has hit a 52-week low of $15.19, reflecting a 26.96% decrease over the past year and a 34% year-to-date decline in 2024. Despite this, InvestingPro analysis suggests the stock may be undervalued, with expected net income growth. The company recently …

Kaplan Fox Reminds Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Seek a Leadership Role Before Deadline on September 28, 2026

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between …

CAPR Shareholder Alert: Capricor Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) on behalf of investors who purchased securities between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor failed to disclose that it changed the statistical …

TD Cowen cuts Capri Holdings to Hold as Michael Kors recovery faces execution risk

Investing.com -- TD Cowen downgraded Capri Holdings to Hold from Buy and lowered its price target to $17, saying the expected recovery at Michael Kors has become increasingly dependent on flawless execution despite early signs of operational improvement. The brokerage said it continues to …

Capri reports lower first-quarter sales, updates outlook

Capri Holdings, the parent company of Jimmy Choo and Michael Kors, posted first-quarter fiscal 2027 earnings ahead of expectations despite a year-on-year (YoY) sales decline while trimming its full-year outlook. For the three months to 27 June 2026, the group recorded revenue of $769m, …

CPRI Q1 Earnings Beat Estimates on Margin Gains, Jimmy Choo Growth

Capri Holdings (CPRI) Stock Drops As Sales Cut Clouds Margin Gains

Capri Holdings Ltd (CPRI) (Q1 2027) Earnings Call Highlights: Strong Profit Growth Amid ...

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Capri Holdings Ltd (NYSE:CPRI) exceeded its own expectations for first-quarter fiscal 2027, delivering revenue, operating …

Levi & Korsinsky Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Capricor Therapeutics (NASDAQ: CAPR) on behalf of investors who purchased shares between December 17, 2025, and July 26, 2026. The lawsuit alleges that Capricor made false or misleading statements, which led to …

Capri Holdings Releases Q1 2027 Financial Results

Capri Holdings Limited reported adjusted earnings of $0.67 per share and revenue of $769.0M for Q1 2027, representing a 3.5% decrease year-over-year. The Michael Kors brand contributed $590.0M to revenue, despite a 7.1% decline in sales, and the company decreased inventory levels by 20.0%. …

Capri Holdings Limited Announces First Quarter Fiscal 2027 Results

Capri Holdings Limited announced first quarter fiscal 2027 results, with revenue, operating income, and earnings per share exceeding expectations. Despite a decline in overall revenue and some headwinds for Michael Kors, the company maintained its fiscal 2027 earnings per share outlook due to strategic …

Here's What Key Metrics Tell Us About Capri Holdings (CPRI) Q1 Earnings

For the quarter ended June 2026, Capri Holdings (CPRI) reported revenue of $769 million, down 3.5% over the same period last year. EPS came in at $0.67, compared to $0.50 in the year-ago quarter. The reported revenue represents a surprise of +2.51% over the …

Capri Holdings beats first-quarter forecasts but lowers revenue guidance

Jimmy Choo shoes ©Adobe Stock Images Capri Holdings (NYSE:CPRI) reported stronger-than-expected first-quarter fiscal 2027 results, surpassing Wall Street forecasts for both earnings and revenue. However, the luxury fashion group reduced its full-year revenue outlook, sending shares modestly lower after the announcement. The company posted …

Capri Holdings (CPRI) Surpasses Q1 Earnings and Revenue Estimates

Capri Holdings (CPRI) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.5 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Capri Holdings Cuts Outlook on Inventory, Middle East Concerns

Shares of Capri Holdings were under pressure in early trading on Wednesday as lower inventory and weakness stemming from the U.S. war with Iran hit the Michael Kors business and pushed down the company's revenue outlook for the year, even after a stronger-than-expected first …

Form 8-K Capri Holdings Ltd For: Aug 05

Capri Holdings Limited filed a Form 8-K with the SEC on August 5, 2026, to report its unaudited financial results for the first fiscal quarter ended June 27, 2026. The filing includes a press release (Exhibit 99.1) detailing these results. This report is submitted …

Earnings Flash (CPRI) Capri Holdings Limited Posts Q1 Adjusted EPS $0.67 per Share, vs. FactSet Est of $0.40

Capri Holdings Limited (CPRI) reported adjusted earnings per share of $0.67 for the first quarter, significantly surpassing FactSet's estimate of $0.40. This positive earnings surprise comes despite the company cutting its 2027 revenue guidance. The article highlights several recent news items related to Capri …